therapeutics: guidelines and beyond
Clostridioides difficile infection (CDI) has become an increasingly common infection both within and outside of the hospital setting. The management of this infection has been evolving as we learn more about the role of the human microbiota in protecting us from this gastrointestinal opportunist. Fo...
Main Authors: | Robert Orenstein, Roberto L. Patron |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-08-01
|
Series: | Therapeutic Advances in Infectious Disease |
Online Access: | https://doi.org/10.1177/2049936119868548 |
Similar Items
-
Recommended guidance beyond guidelines
by: Höschl Cyril
Published: (2010-04-01) -
Paediatric antiretroviral therapy - Beyond the Guidelines
by: Leon Levin
Published: (2000-07-01) -
Managing Ulcerative Colitis – The Guidelines and Beyond
by: Mitchell RKL Lie, et al.
Published: (2013-11-01) -
Spinal tuberculosis - Treatment options beyond guidelines
by: Ines Esteves Cruz, Pedro Ferreira, Sara Brandao Machado, Joao Mourato Torres, Ana Claudia Miranda, Isabel Antunes
Published: (2020-02-01) -
Nutraceuticals and dyslipidaemia: Beyond the common therapeutics
by: Pietro Scicchitano, et al.
Published: (2014-01-01)